Status:
RECRUITING
Effects of Oncological Treatment During Pregnancy on Mother and Child
Lead Sponsor:
University Hospital, Gasthuisberg
Collaborating Sponsors:
The Netherlands Cancer Institute
Erasmus Medical Center
Conditions:
Cancer
Pregnancy
Eligibility:
FEMALE
18+ years
Brief Summary
The researchers aim to investigate the outcome (overall survival) of mothers who are diagnosed and/or treated for cancer during pregnancy. Furthermore they want to test the hypothesis that children wh...
Detailed Description
Study contains several study parts (protocol version 4.4): \*\*\*\*\*\*\*\*\*\*Part I. Pregnancy, delivery and maternal health\*\*\*\*\*\*\*\*\*\* Part I.I.A. Registration study 'Cancer during pregna...
Eligibility Criteria
Inclusion
- Patients do not need to participate in both; however, preferentially both study parts should be performed.
- \*\*\*\*\*\*\*\*\*\*\*\*\*\*Part I: Pregnancy, delivery and maternal health\*\*\*\*\*\*\*\*\*\*\*\*\*\*
- Patients must meet the following inclusion criteria:
- Histologically proven cancer in association with a pregnancy (during pregnancy or cancer dagnosis within 5 years after pregnancy)
- \> 18 years of age, premenopausal
- Patients who have given their signed and written informed consent to participate in the trial after fully understanding the implication of the protocol
- Women receiving any cytotoxic drug or radiation therapy during pregnancy are allowed for the assessment of the maternal and fetal outcome (Part II).
Exclusion
- Mentally disabled or significantly altered mental status that would prohibit the understanding and giving of informed consent
- \*\*\*\*\*\*\*\*\*\*\*\*\*\*Part II: Follow-up of children\*\*\*\*\*\*\*\*\*\*\*\*\*\*
- Inclusion Criteria:
- \- Children that were prenatally exposed to cancer of cancer treament. Informed Consent is asked from parents. From the age of 12 years, informed assent is additionally asked from the child. After the age of 18 years, informed consent is solely asked of the offspring.
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2032
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT00330447
Start Date
August 1 2005
End Date
December 1 2032
Last Update
March 6 2024
Active Locations (33)
Enter a location and click search to find clinical trials sorted by distance.
1
Cooper University Hospital (2015-ongoing)
Camden, New Jersey, United States, 08103
2
Instituto Alexander Fleming
Buenos Aires, Argentina
3
Universitätsklinik für Frauenheilkunde und Geburtshilfe (retrospective 2016-2018)
Graz, Austria
4
UCL Brussels (2013-ongoing)
Brussels, Belgium